Clinical trial
Development of a Peripheral Blood Assay to Replace Bone Marrow Biopsy in Myeloproliferative Neoplasms- a Multi-center Observational Study
NCT07648433 is registered in ClinicalTrials.gov with Weizmann Institute of Science as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development of a Peripheral Blood Assay to Replace Bone Marrow Biopsy in Myeloproliferative Neoplasms- a Multi-center Observational Study
- Lead sponsor
- Weizmann Institute of Science
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- October 31, 2026
- Completion date
- June 30, 2032
- Enrollment
- 500 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
myeloproliferative neoplasm